Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis

To determine the proportion of fluconazole-resistant Candida albicans isolates that have clinically significant cross-resistance to itraconazole or ketoconazole, that is sufficient to result in failure of these agents at their standard doses (200 and 400 mg daily for 7 days, respectively). Seven hun...

Ausführliche Beschreibung